Michael Rosenblatt

Michael Rosenblatt

Direktor/Vorstandsmitglied bei PYC THERAPEUTICS LIMITED

Vermögen: 671 663 $ am 30.04.2024

76 Jahre
Health Technology
Health Services
Consumer Services

Profil

Michael A.
Rosenblatt
is the founder of Theracrine, Inc. (founded in 2006) and Radius Health, Inc. (founded in 2003).
He is currently an Independent Director at Azenta, Inc. (since 2018), a Non-Executive Director at PYC Therapeutics Ltd.
(since 2021), a Director at Ferring Pharmaceuticals, Inc. (since 2016), a Non-Executive Director at Perspectum Ltd., a Director at Ohana Biosciences, Inc. (since 2016), a Director at Cygnal Therapeutics, Inc. (since 2016), a Director at Perspectum Group Ltd., a Senior Advisor at Flagship Pioneering, and an Advisor at PureTech Health LLC.
He has held former positions as a Non-Executive Director at Shire Plc (2008-2008, 2008-2009), a Director at ProScript, Inc., a Director at Project HOPE-The-People-To-People Health Foundation, Inc., a Director at Harvard Mit Health Sciences & Technology (1992-1998), an Independent Director at Axcella Health, Inc. (2022-2023), an Independent Director at Rubius Therapeutics, Inc. (2014-2023), a Director at Cobalt Biomedicine, Inc., the Chief Medical Officer & Executive Vice President at Merck & Co., Inc. (1984-2016), the Chief Medical Officer at Schering-Plough Corp., a Principal at The General Hospital Corp.
(1981-1984), a Senior Vice President-Academic Programs at CareGroup, Inc. (1996-2000), the President at Beth Israel Deaconess Medical Center, Inc. (1996-2003), a Member-Scientific Counselors Board at National Institute of Diabetes & Digestive & Kidney Diseases, a Senior Vice President-Research at Merck Research Laboratories Massachusetts LLC, a Professor at Harvard Medical School, and a Senior Vice President-Research at Merck Sharp & Dohme Corp.
(1984-1992).
He has an undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from Harvard Medical School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
12.02.2024 13 042 ( 0,02% ) 671 663 $ 30.04.2024
31.10.2023 0 ( -.--% ) - $ 31.12.2023
30.06.2023 0 ( -.--% ) - $ 30.04.2024

Aktive Positionen von Michael Rosenblatt

UnternehmenPositionBeginn
AZENTA, INC. Direktor/Vorstandsmitglied 05.09.2018
PYC THERAPEUTICS LIMITED Direktor/Vorstandsmitglied 17.03.2021
Direktor/Vorstandsmitglied 25.02.2022
Direktor/Vorstandsmitglied -
Berater 01.01.2022
Direktor/Vorstandsmitglied 01.01.2016
Direktor/Vorstandsmitglied 01.01.2016
Corporate Officer/Principal 29.12.2010
Direktor/Vorstandsmitglied 01.01.2016
Alle aktiven Positionen von Michael Rosenblatt

Ehemalige bekannte Positionen von Michael Rosenblatt

UnternehmenPositionEnde
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Michael Rosenblatt im Detail an

Ausbildung von Michael Rosenblatt

The Trustees of Columbia University in The City of New York Undergraduate Degree
Harvard Medical School Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michael Rosenblatt im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
MERCK & CO., INC.

Health Technology

AZENTA, INC.

Health Services

PYC THERAPEUTICS LIMITED

Health Technology

AXCA HEALPAR

Health Technology

Private Unternehmen23

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Finance

Health Technology

Finance

Commercial Services

Health Services

Health Technology

Health Services

National Institute of Diabetes & Digestive & Kidney Diseases

Government

Health Technology

Health Technology

Health Technology

Health Services

Molecular Medicine LLC

Health Technology

Commercial Services

Health Technology

Health Technology

Technology Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Michael Rosenblatt